Shopping Cart
Remove All
Your shopping cart is currently empty
Fostroxacitabine bralpamide (MIV-818) is an orally active, Troxacitabine-based nucleotide prodrug with anticancer effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | Backorder | Backorder |
| Description | Fostroxacitabine bralpamide (MIV-818) is an orally active, Troxacitabine-based nucleotide prodrug with anticancer effects. |
| In vitro | Fostroxacitabine bralpamide (MIV-818) undergoes significant metabolism by human hepatocytes, resulting in elevated concentrations of the chain-terminating nucleotide tri-phosphate in the liver. This tri-phosphate incorporates into DNA during the replication process, culminating in DNA double-strand breaks, eliciting DNA damage responses, and inducing cytotoxicity[1]. |
| Synonyms | MIV-818 |
| Molecular Weight | 589.37 |
| Formula | C22H30BrN4O8P |
| Cas No. | 2129993-56-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.